Ind-Swift gains on rumor of Piramal's interest in research and manufacturing unit
This article was originally published in Scrip
Executive Summary
Shares of the active pharmaceutical ingredients firm, Ind-Swift Laboratories, rose sharply on Indian bourses amid speculation that Piramal Healthcare may be eying its contract research and manufacturing services business.